EUR 6.05
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 183.43 Million EUR | 7.77% |
2022 | 170.2 Million EUR | -17.73% |
2021 | 206.89 Million EUR | -2.5% |
2020 | 212.2 Million EUR | 3.87% |
2019 | 204.29 Million EUR | 5.07% |
2018 | 194.42 Million EUR | 0.47% |
2017 | 193.52 Million EUR | 15.31% |
2016 | 167.82 Million EUR | 20.61% |
2015 | 139.14 Million EUR | 8.44% |
2014 | 128.31 Million EUR | -15.93% |
2013 | 152.61 Million EUR | 26.27% |
2012 | 120.86 Million EUR | 12.08% |
2011 | 107.84 Million EUR | 8.33% |
2010 | 99.54 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q4 | 183.43 Million EUR | 0.0% |
2023 Q2 | 173.91 Million EUR | 0.0% |
2022 FY | 170.2 Million EUR | -17.73% |
2022 Q2 | 207.74 Million EUR | 0.0% |
2022 Q4 | 170.2 Million EUR | 0.0% |
2021 Q2 | 206.73 Million EUR | 0.0% |
2021 Q4 | 206.89 Million EUR | 0.0% |
2021 FY | 206.89 Million EUR | -2.5% |
2020 Q4 | 212.2 Million EUR | 0.0% |
2020 Q2 | 213.22 Million EUR | 0.0% |
2020 FY | 212.2 Million EUR | 3.87% |
2019 Q4 | 204.29 Million EUR | 0.0% |
2019 Q2 | 186.13 Million EUR | 0.0% |
2019 FY | 204.29 Million EUR | 5.07% |
2018 FY | 194.42 Million EUR | 0.47% |
2018 Q4 | 194.42 Million EUR | 0.0% |
2018 Q2 | 183.14 Million EUR | 0.0% |
2017 Q2 | 172.63 Million EUR | 0.0% |
2017 FY | 193.52 Million EUR | 15.31% |
2017 Q4 | 193.52 Million EUR | 0.0% |
2016 Q4 | 167.82 Million EUR | 0.0% |
2016 FY | 167.82 Million EUR | 20.61% |
2016 Q2 | 160.89 Million EUR | 0.0% |
2015 Q2 | 120.3 Million EUR | 0.0% |
2015 Q4 | 139.14 Million EUR | 0.0% |
2015 FY | 139.14 Million EUR | 8.44% |
2014 FY | 128.31 Million EUR | -15.93% |
2014 Q4 | 128.31 Million EUR | 0.0% |
2014 Q2 | 172.68 Million EUR | 0.0% |
2013 Q4 | 142.74 Million EUR | 0.0% |
2013 FY | 152.61 Million EUR | 26.27% |
2012 FY | 120.86 Million EUR | 12.08% |
2011 FY | 107.84 Million EUR | 8.33% |
2010 FY | 99.54 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Crossject Société Anonyme | 33.9 Million EUR | -441.081% |
Safe Orthopaedics SA | 17.79 Million EUR | -930.691% |
Spineway SA | 7.25 Million EUR | -2427.656% |
Sartorius Stedim Biotech S.A. | 5.07 Billion EUR | 96.388% |
EssilorLuxottica Société anonyme | 21.63 Billion EUR | 99.152% |
bonyf N.V. | 411.93 Thousand EUR | -44429.247% |